Posted
Video length: 2 min.
Article written by
Research against cancer is progressing, especially for lung cancer, the one that causes the most deaths. A drug has been developed by researchers that can halve mortality. The point with Damien Mascret, doctor and journalist, on the set of 12/13.
A drug, the results of which have been revealed, could reduce the number of deaths linked to lung cancer. “Din certain lung cancers with a particular mutation called EGRF, THE new treatment, the TAGRESSO, allows you to get a survival 88% at five years. VSshe means 12% mortality”, explains doctor Damien Mascret. The mortality rate is 22% without treatment. “We therefore go from 22 to 12% of mortality with this treatment. It’s almost half as much”, continues the journalist and doctor.
Researchers seek to ease patients’ pain
Oncologists are also trying to lighten treatments. This is particularly the case against rectal cancer. “During treatment, iThere is always surgery, and sometimes chemotherapy and radiotherapy. This last has many side effects. whatweyou tested the Americans is not to add the radiotherapy in one case. And the results are the same with or without”, underlines Damien Mascret.
View comments